Trial intelligence / Profile preview

PRF vs Melatonin Gel for Dental Implant Osseointegration

NCT05593731Phase 2Completed

Sponsor
Misr University for Science and Technology
Start
Dec 2021
Primary completion
Jul 2022
Modality
Small Molecules, Cell Therapies
Countries
1
01

Overview

Phase 2, randomised trial of Mucomel and platelet-rich fibrin cream (Poznan University of Medical Sciences) in tooth loss, sponsored by Misr University for Science and Technology. Primary endpoint: Gingival thickness at 6 months. Started Dec 2021; status: completed.

02

Drugs

Mucomelplatelet-rich fibrin cream (Poznan University of Medical Sciences)
03

Conditions

tooth loss

Beyond the preview

Go deeper on NCT05593731.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05593731.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call